Featured Research

from universities, journals, and other organizations

Engineered Blood Vessels Function Like Native Tissue

Date:
July 10, 2007
Source:
University at Buffalo
Summary:
Blood vessels that have been tissue-engineered from bone marrow adult stem cells may in the future serve as a patient's own source of new blood vessels following a coronary bypass or other procedures that require vessel replacement, according to new research.

UB researchers have developed a method to produce blood vessels tissue-engineered from bone marrow adult stem cells.
Credit: Image courtesy of University at Buffalo

Blood vessels that have been tissue-engineered from bone marrow adult stem cells may in the future serve as a patient's own source of new blood vessels following a coronary bypass or other procedures that require vessel replacement, according to new research from the University at Buffalo Department of Chemical and Biological Engineering.

Related Articles


"Our results show that bone marrow is an excellent source of adult stem cells containing smooth muscle and endothelial cells, and that these stem cells can be used in regenerative medicine for cardiovascular applications," said Stelios T. Andreadis, Ph.D., associate professor in the UB Department of Chemical and Biological Engineering in the School of Engineering and Applied Sciences.

Andreadis co-authored the paper, published recently in Cardiovascular Research, with Jin Yu Liu, Ph.D., lead author and a post doctoral researcher in Andreadis' lab.

The research demonstrates the potential for eventually growing tissue-engineered vessels out of stem cells harvested from the patients who need them, providing a desirable alternative to the venous grafts now routinely done in patients undergoing coronary bypass operations.

Disadvantages with venous grafts include limited availability of vessels, pain and discomfort at the donor site and a high 10-year failure rate.

The UB researchers developed a novel method for isolating functional smooth muscle cells from bone marrow by using a fluorescent marker protein and a tissue-specific promoter for alpha-actin, a protein found in muscles that is responsible for their ability to contract and relax.

Although not yet strong enough for coronary applications, the UB group's tissue-engineered vessels (TEVs) performed similarly to native tissue in critical ways, including their morphology, their expression of several smooth muscle cell proteins, the ability to proliferate and the ability to contract in response to vasoconstrictors, one of the most important properties of blood vessels.

The TEVs also produced both collagen and elastin, which give connective tissue their strength and elasticity and are critical to the functioning of artificial blood vessels.

"These are the first tissue-engineered vessels to demonstrate the ability to make elastin in vivo," said Andreadis.

In addition, the smooth muscle cells isolated from the bone marrow are mesenchymal cells, that is, stem cells that can differentiate into several cell types.

Several studies have shown that mesenchymal stem cells may be immunoprivileged, which means they will not trigger an immune reaction when transplanted into another individual, Andreadis said.

"If true, this means that you may be able to develop a universal cell source for smooth muscle cells, so that you could potentially make these vessels into an 'off-the-shelf' product, available to any patient," Andreadis said.

The TEVs were implanted into sheep and functioned normally for five weeks.

Andreadis' group now is working on ways to make the TEVs stronger. It also is studying the differences between stem cells taken from older versus younger individuals, work that is being funded by the John R. Oishei Foundation.

Co-authors on the paper with Andreadis and J.Y. Liu include Daniel D. Swartz, Ph.D., research assistant professor at Women and Children's Hospital of Buffalo; Sylvia F. Gugino, UB senior research support specialist; James A. Russell, Ph.D., in the UB Department of Physiology and Biophysics; and Hao Fan Peng, graduate student in the Department of Chemical and Biological Engineering.

Funding for the current work came from UB's Integrative Research and Creative Activities Fund in the UB Office of the Vice President for Research.


Story Source:

The above story is based on materials provided by University at Buffalo. Note: Materials may be edited for content and length.


Cite This Page:

University at Buffalo. "Engineered Blood Vessels Function Like Native Tissue." ScienceDaily. ScienceDaily, 10 July 2007. <www.sciencedaily.com/releases/2007/07/070705152928.htm>.
University at Buffalo. (2007, July 10). Engineered Blood Vessels Function Like Native Tissue. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/2007/07/070705152928.htm
University at Buffalo. "Engineered Blood Vessels Function Like Native Tissue." ScienceDaily. www.sciencedaily.com/releases/2007/07/070705152928.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Reuters - Innovations Video Online (Dec. 21, 2014) A team of scientists led by Danish chemist Jorn Christensen says they have isolated two chemical compounds within an existing antipsychotic medication that could be used to help a range of failing antibiotics work against killer bacterial infections, such as Tuberculosis. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com
Hugging It Out Could Help You Ward Off A Cold

Hugging It Out Could Help You Ward Off A Cold

Newsy (Dec. 21, 2014) Carnegie Mellon researchers found frequent hugs can help people avoid stress-related illnesses. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins